The operation in Kabul, Afghanistan, is proving to be a significant player in the regional supply system for Abacavir Sulphate drug substance. This Afghan manufacturing capability represents a substantial step beyond for the Afghan pharmaceutical industry and delivers a distinct opportunity to decrease dependence on overseas providers. The generati